Viewing Study NCT00374868


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-05-28 @ 5:57 AM
Study NCT ID: NCT00374868
Status: COMPLETED
Last Update Posted: 2010-11-04
First Post: 2006-09-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable)
Sponsor: Eli Lilly and Company
Organization: